These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Statin therapy and SAR-COV-2: an available and potential therapy? Abdel-Latif RG; Mohammed S; Elgendy IY Eur Heart J Cardiovasc Pharmacother; 2020 Sep; 6(5):333-334. PubMed ID: 32379307 [No Abstract] [Full Text] [Related]
8. Scientific research progress of COVID-19/SARS-CoV-2 in the first five months. Li H; Liu Z; Ge J J Cell Mol Med; 2020 Jun; 24(12):6558-6570. PubMed ID: 32320516 [TBL] [Abstract][Full Text] [Related]
9. Fighting COVID-19: A quick review of diagnoses, therapies, and vaccines. Shih HI; Wu CJ; Tu YF; Chi CY Biomed J; 2020 Aug; 43(4):341-354. PubMed ID: 32532623 [TBL] [Abstract][Full Text] [Related]
11. COVID-19 - Toward a comprehensive understanding of the disease. Kowalik MM; Trzonkowski P; Łasińska-Kowara M; Mital A; Smiatacz T; Jaguszewski M Cardiol J; 2020; 27(2):99-114. PubMed ID: 32378729 [TBL] [Abstract][Full Text] [Related]
12. Antiviral Efficacies of FDA-Approved Drugs against SARS-CoV-2 Infection in Ferrets. Park SJ; Yu KM; Kim YI; Kim SM; Kim EH; Kim SG; Kim EJ; Casel MAB; Rollon R; Jang SG; Lee MH; Chang JH; Song MS; Jeong HW; Choi Y; Chen W; Shin WJ; Jung JU; Choi YK mBio; 2020 May; 11(3):. PubMed ID: 32444382 [TBL] [Abstract][Full Text] [Related]
14. Broad Anti-coronavirus Activity of Food and Drug Administration-Approved Drugs against SARS-CoV-2 Weston S; Coleman CM; Haupt R; Logue J; Matthews K; Li Y; Reyes HM; Weiss SR; Frieman MB J Virol; 2020 Oct; 94(21):. PubMed ID: 32817221 [TBL] [Abstract][Full Text] [Related]
15. SARS-CoV-2 pandemic and research gaps: Understanding SARS-CoV-2 interaction with the ACE2 receptor and implications for therapy. Datta PK; Liu F; Fischer T; Rappaport J; Qin X Theranostics; 2020; 10(16):7448-7464. PubMed ID: 32642005 [TBL] [Abstract][Full Text] [Related]
16. Overview of lethal human coronaviruses. Chen B; Tian EK; He B; Tian L; Han R; Wang S; Xiang Q; Zhang S; El Arnaout T; Cheng W Signal Transduct Target Ther; 2020 Jun; 5(1):89. PubMed ID: 32533062 [TBL] [Abstract][Full Text] [Related]
17. Interplay between SARS-CoV-2 and the type I interferon response. Sa Ribero M; Jouvenet N; Dreux M; Nisole S PLoS Pathog; 2020 Jul; 16(7):e1008737. PubMed ID: 32726355 [TBL] [Abstract][Full Text] [Related]
18. Immunoinformatics-guided designing of epitope-based subunit vaccines against the SARS Coronavirus-2 (SARS-CoV-2). Sarkar B; Ullah MA; Johora FT; Taniya MA; Araf Y Immunobiology; 2020 May; 225(3):151955. PubMed ID: 32517882 [TBL] [Abstract][Full Text] [Related]
19. [Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): Should we target the virus, the cell or the disease?]. Nisole S; Saulnier A; Gatignol A Virologie (Montrouge); 2020 Jun; 24(3):135-141. PubMed ID: 32648548 [No Abstract] [Full Text] [Related]